SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,414,978 | +17.2% | 68,755 | +167.7% | 0.08% | +20.0% |
| Q2 2023 | $1,207,427 | -7.6% | 25,679 | -17.5% | 0.06% | -19.8% |
| Q1 2023 | $1,306,802 | +173.4% | 31,144 | +170.7% | 0.08% | +200.0% |
| Q2 2020 | $478,000 | +70.7% | 11,507 | +18.1% | 0.03% | +28.6% |
| Q1 2020 | $280,000 | -70.8% | 9,741 | -26.7% | 0.02% | -50.0% |
| Q4 2019 | $959,000 | -42.5% | 13,288 | +11.8% | 0.04% | -50.0% |
| Q3 2019 | $1,668,000 | -27.7% | 11,887 | -5.7% | 0.08% | -22.9% |
| Q2 2019 | $2,307,000 | +3.6% | 12,600 | -10.0% | 0.11% | +1.9% |
| Q1 2019 | $2,226,000 | +80.7% | 13,993 | +8.8% | 0.11% | +40.8% |
| Q4 2018 | $1,232,000 | -45.4% | 12,866 | -19.4% | 0.08% | -11.6% |
| Q3 2018 | $2,255,000 | – | 15,967 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |